ARVN
Biotechnology · Healthcare
CEO, CFO
2024-02-29–present
Equibles does not estimate personal net worth.
Get an email with a short summary when Arvinas, Inc. publishes a filing, an earnings call transcript or a press release.
Get ARVN alertsRandy Teel is recorded as CFO at Arvinas, Inc. (ARVN) since February 29, 2024 and CEO at Arvinas, Inc. (ARVN). Arvinas, Inc. reported in an 8-K filed February 20, 2024 that Randy Teel was appointed interim Chief Financial Officer, Treasurer and principal financial officer, effective February 29, 2024. The proxy statement of Arvinas, Inc. reports total compensation of $3,776,333 for Randy Teel in fiscal 2024, including a base salary of $474,998. Randy Teel has spoken on 3 earnings calls and 1 other investor event across 1 company, most recently for Arvinas, Inc. on August 4, 2026. Arvinas, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Arvinas, Inc. includes Randy Teel, Ph.D. (CEO and Board Member), Briggs Morrison, M.D. (Chairman), David Loomis (Chief Accounting Officer) and 6 others.
“On February 19, 2024, the Board of Directors of the Company appointed Randy Teel, Ph.D., the Company’s current Senior Vice President, Corporate and Business Development, to serve as the Company’s interim Chief Financial Officer, Treasurer and principal financial officer, effective February 29, 2024, while the Company undertakes a search to identify the Company’s next permanent Chief Financial Officer, Treasurer and principal financial officer.”
“As a company, we've made significant progress over the past several months. Our focus has been on positioning our VNS for our next phase of growth, guided by a clear strategic vision.”
“Yeah, I thought I'd start off with just a very quick high-level overview before we dive into the Q&A. We're Arvinus. Make pro-tech degraders. I've been around for quite a while now, over 10 years. and had a recent approval, which we'll get into just in a couple minutes.”
“Yeah, I thought I'd start off with just a very quick high-level overview before we dive into the Q&A. We're Arvinus. Make pro-tech degraders. I've been around for quite a while now, over 10 years. and had a recent approval, which we'll get into just in a couple minutes.”
“Yeah, I thought I'd start off with just a very quick high-level overview before we dive into the Q&A. We're Arvinus. Make pro-tech degraders. I've been around for quite a while now, over 10 years. and had a recent approval, which we'll get into just in a couple minutes.”
2024-02-29–present
ARVN
Biotechnology · Healthcare
CEO, CFO
2024-02-29–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Arvinas, Inc. (ARVN) | Former interim Chief Financial Officer | $474,998 | $3,776,333 |